1. Home
  2. SPCB vs NSRX Comparison

SPCB vs NSRX Comparison

Compare SPCB & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$10.37

Market Cap

39.8M

Sector

Technology

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.25

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
NSRX
Founded
1988
2019
Country
Israel
Israel
Employees
N/A
7
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8M
32.2M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
SPCB
NSRX
Price
$10.37
$3.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
65.0K
42.9K
Earning Date
04-28-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
N/A
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$1.98
52 Week High
$13.57
$9.99

Technical Indicators

Market Signals
Indicator
SPCB
NSRX
Relative Strength Index (RSI) 47.56 53.20
Support Level $9.76 $2.04
Resistance Level $10.86 $3.58
Average True Range (ATR) 0.70 0.32
MACD -0.21 -0.01
Stochastic Oscillator 24.19 42.15

Price Performance

Historical Comparison
SPCB
NSRX

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: